Pakistan is hit by a shortage of anti-tuberculosis drugs

Pakistan is facing a severe shortage of drugs to treat tuberculosis (TB)—most notably ethambutol and pyrazinamide which are used to treat complex cases—because the government and the pharmaceutical industry have not been able to come to an agreement over pricing.